SBH
INVA icon

Segall Bryant & Hamill’s Innoviva INVA Stock Holding History

Segall Bryant & Hamill’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
45,762
+5,529
+14% +$127K 0.01% 538
2026
Q1 		$937K Sell
40,233
-133
-0.3% -$2.87K 0.01% 514
2025
Q4 		$807K Buy
40,366
+9,513
+31% +$186K 0.01% 521
2025
Q3 		$563K Sell
30,853
-5,904
-16% -$115K 0.01% 540
2025
Q2 		$738K Sell
36,757
-110
-0.3% -$2.12K 0.01% 522
2025
Q1 		$668K Hold
36,867
– – 0.01% 532
2024
Q4 		$640K Sell
36,867
-172
-0.5% -$3.3K 0.01% 544
2024
Q3 		$715K Buy
+37,039
New +$683K 0.01% 531

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Segall Bryant & Hamill's INVA Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Innoviva (INVA) stake by 14% in Q2 2026, buying an estimated $127K and bringing the position to 45,762 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #538.

Segall Bryant & Hamill first reported a position in INVA in Q3 2024 and has held it in 8 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Segall Bryant & Hamill held 45,762 shares of Innoviva worth $1.04M as of Q2 2026.
  • Segall Bryant & Hamill bought 5,529 Innoviva shares in Q2 2026, an estimated $127K.
  • Innoviva made up 0.01% of Segall Bryant & Hamill's portfolio in Q2 2026, its #538 holding.
  • Segall Bryant & Hamill first reported a position in Innoviva in Q3 2024 and has held it in 8 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.